Question

A 64-year-old man with type 2 diabetes, established coronary artery disease, and eGFR 45 mL/min/1.73 m² has an HbA1c of 7.8% despite maximal tolerated metformin. According to Diabetes Canada, which additional agent is preferred to improve both glycaemic control and cardiorenal outcomes?

Accepted Answer

SGLT2 inhibitor

Answer

Dipeptidyl peptidase-4 (DPP-4) inhibitor

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

Basal insulin

Practice question

A 64-year-old man with type 2 diabetes, established coronary artery disease, and eGFR 45 mL/min/1.73 m² has an HbA1c of 7.8% despite maximal tolerated metformin. According to Diabetes Canada, which additional agent is preferred to improve both glycaemic control and cardiorenal outcomes?